Dasotraline
Dasotraline (INN) (former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that is under development by Sunovion for clinical use. The drug is no longer being developed for major depressive disorder (MDD), but is still under investigation for the treatment of attention-deficit hyperactivity disorder (ADHD) and eating disorders.
See also
References
Further reading
This page contains text from Wikipedia, the Free Encyclopedia - https://wn.com/Dasotraline
Podcasts:
PLAYLIST TIME: